CMPX
Price
$1.50
Change
-$0.01 (-0.66%)
Updated
Dec 24 closing price
84 days until earnings call
IPSC
Price
$1.02
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
78 days until earnings call
Ad is loading...

CMPX vs IPSC

Header iconCMPX vs IPSC Comparison
Open Charts CMPX vs IPSCBanner chart's image
Compass Therapeutics
Price$1.50
Change-$0.01 (-0.66%)
Volume$134.47K
CapitalizationN/A
Century Therapeutics
Price$1.02
Change-$0.00 (-0.00%)
Volume$516.03K
CapitalizationN/A
CMPX vs IPSC Comparison Chart
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. IPSC commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Hold and IPSC is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (CMPX: $1.50 vs. IPSC: $1.02)
Brand notoriety: CMPX and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 29% vs. IPSC: 81%
Market capitalization -- CMPX: $206.38M vs. IPSC: $87.15M
CMPX [@Biotechnology] is valued at $206.38M. IPSC’s [@Biotechnology] market capitalization is $87.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, CMPX is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 4 bullish TA indicator(s).

  • CMPX’s TA Score: 3 bullish, 6 bearish.
  • IPSC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than CMPX.

Price Growth

CMPX (@Biotechnology) experienced а -1.96% price change this week, while IPSC (@Biotechnology) price change was -12.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

CMPX is expected to report earnings on Mar 19, 2025.

IPSC is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($206M) has a higher market cap than IPSC($87.2M). CMPX YTD gains are higher at: -3.846 vs. IPSC (-69.127). CMPX has higher annual earnings (EBITDA): -53.58M vs. IPSC (-117.21M). IPSC has more cash in the bank: 198M vs. CMPX (135M). CMPX has less debt than IPSC: CMPX (6.88M) vs IPSC (54.6M). IPSC has higher revenues than CMPX: IPSC (2.68M) vs CMPX (850K).
CMPXIPSCCMPX / IPSC
Capitalization206M87.2M236%
EBITDA-53.58M-117.21M46%
Gain YTD-3.846-69.1276%
P/E RatioN/AN/A-
Revenue850K2.68M32%
Total Cash135M198M68%
Total Debt6.88M54.6M13%
TECHNICAL ANALYSIS
Technical Analysis
CMPXIPSC
RSI
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NFEPX21.480.26
+1.23%
Columbia Large Cap Growth Opp Inst
ICSSX16.950.14
+0.83%
VY® Columbia Small Cap Value II S
MDPIX126.940.93
+0.74%
ProFunds Mid Cap Inv
JHDCX18.61N/A
N/A
JPMorgan Hedged Equity 2 C
GCIEX7.61N/A
N/A
Gabelli Equity Income I

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-0.66%
TRDA - CMPX
44%
Loosely correlated
+0.57%
ABOS - CMPX
41%
Loosely correlated
+1.13%
ABCL - CMPX
40%
Loosely correlated
+1.03%
IPSC - CMPX
40%
Loosely correlated
+0.49%
FHTX - CMPX
40%
Loosely correlated
+1.83%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with NKTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+0.49%
NKTX - IPSC
49%
Loosely correlated
-6.00%
CRSP - IPSC
45%
Loosely correlated
+1.14%
PGEN - IPSC
45%
Loosely correlated
+5.24%
ARVN - IPSC
45%
Loosely correlated
+4.06%
FATE - IPSC
44%
Loosely correlated
N/A
More